BFM
CUE icon

Boothbay Fund Management’s Cue Biopharma CUE Stock Holding History

Boothbay Fund Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$993K Buy
+31,459
New +$711K 0.01% 1098
2026
Q1 		– Sell
-23,477
Closed -$215K – 2146
2025
Q4 		$215K Buy
23,477
+3,112
+15% +$57.2K ﹤0.01% 1631
2025
Q3 		$439K Buy
+20,365
New +$478K 0.01% 1241
2022
Q3 		– Sell
-412
Closed -$31K – 2302
2022
Q2 		$31K Buy
+412
New +$48.2K ﹤0.01% 2158

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

Boothbay Fund Management's CUE Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Cue Biopharma (CUE) in Q2 2026: 31,459 shares worth $993K. The stake represents 0.01% of the portfolio and ranks #1098 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in CUE as recently as Q4 2025.

Boothbay Fund Management first reported a position in CUE in Q2 2022 and has held it in 4 quarters since. 49 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • Boothbay Fund Management held 31,459 shares of Cue Biopharma worth $993K as of Q2 2026.
  • Cue Biopharma was a new Boothbay Fund Management position in Q2 2026.
  • Cue Biopharma made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1098 holding.
  • Boothbay Fund Management first reported a position in Cue Biopharma in Q2 2022 and has held it in 4 quarters since.
  • 49 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.